OSR Health (OSRH)
NasdaqMarket Closed
OSR Holdings, Inc. is a healthcare company focused on developing and commercializing therapies, medical technologies, and related healthcare solutions. The company’s strategy centers on building a portfolio that addresses serious diseases and conditions where existing treatment options may be limited or where innovation can improve patient outcomes. Its activities span drug development, biologics, and medical device distribution, giving it exposure to several areas of the healthcare market.
The company’s therapeutic work includes programs involving oral immunotherapies for cancer and biologics designed for age-related and degenerative diseases. These areas reflect broader trends in medicine toward targeted immune-based treatments, improved delivery methods, and technologies that may support longer, healthier lives. OSR Holdings’ disclosed pipeline includes assets and platforms such as Vaximm, Darnatein, Woori IO, and RMC, each contributing to its broader development strategy.
In addition to its biopharmaceutical interests, OSR Holdings is involved in neurovascular intervention medical devices and systems distribution in Korea. This part of the business connects the company to hospital and specialist markets that treat stroke and other vascular conditions affecting the brain. Medical device distribution can provide commercial infrastructure and market relationships alongside longer-cycle therapeutic development.
As a listed healthcare company, OSR Holdings is positioned in a sector where clinical progress, regulatory milestones, partnerships, and capital availability can strongly influence value. Its distinctive profile comes from combining oncology, biologics, degenerative disease research, and neurovascular device-related operations rather than relying on a single product category.
Last updated
- Market Cap
- $16,154,598
- P/E
- —
- P/FCF
- —
- P/S
- 6.15
- Enterprise Value
- $19,494,647
- Sector
- Industrials
- Industry
- Surgical and Medical Instruments and Apparatus
- Address
- 10900 NE 4TH STREET, SUITE 2300, BELLEVUE, WA, 98004
CEO Statement to Shareholders
Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
BC-Most Active Stocks
Form 8K OSR Holdings Inc For: 20 August
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $16,154,598
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $19,494,647
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.16
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 6.15
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -2.03
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 7.42
- EPS
- -0.27
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -$5,268,602
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -9.19%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -5.55%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.05
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.16
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.14
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.09
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $690,693
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 0.46
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 484.06K | 381.27K | 627.75K | 1.14M | 761.27K |
| Cost of revenue | 323.78K | 251.57K | 366.01K | 1.1M | 592.59K |
| Gross profit | 160.28K | 129.7K | 261.73K | 32.78K | 168.69K |
| Operating income | -3.67M | -6.39M | -3.8M | -5.23M | -2.92M |
| EBITDA | -1.24M | -4.09M | -1.42M | -2.88M | -644.63K |
| Net income | -2.93M | -4.82M | -2.13M | 331.41K | -11.39M |
| Income taxes | -452.31K | -534.87K | -1.29M | 0 | 0 |
| Interest expense | -31.22K | -409K | -43.87K | -36.93K | -16.4K |
| Other operating expenses | 0 | 0 | 0 | -1 | 0 |
| Total operating expenses | 3.83M | 6.52M | 4.07M | 5.26M | 3.09M |
| Basic EPS | -0.09 | -0.16 | -0.1 | 0.02 | -1.04 |
| Diluted EPS | -0.09 | -0.11 | -0.1 | 0.02 | -1.04 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 172.19M | 171.24M | 177.29M | 185.42M | 174.55M |
| Total liabilities | 44.8M | 44.2M | 43.13M | 46.26M | 42.27M |
| Total equity | 127.39M | 127.04M | 134.16M | 139.15M | 132.28M |
| Cash & equivalents | 1.57M | 1.7M | 2.18M | 1.58M | 1.6M |
| Current assets | 2.92M | 2.82M | 3.2M | 2.88M | 3.47M |
| Current liabilities | 17.9M | 17.17M | 15.03M | 15.86M | 13.88M |
| Accounts payable | 8.26M | 7.83M | 0 | 0 | 0 |
| Receivables | 319.65K | 392.1K | 533.93K | 751.25K | 799.54K |
| Inventories | 462.46K | 196.43K | 185.1K | 198.83K | 736.63K |
| Goodwill | 29.73M | 24.95M | 25.53M | 26.39M | 24.41M |
| Long-term debt | 272.91K | 0 | 0 | 0 | 253.04K |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -1M | -1.07M | -2.71M | -482.61K | -64.07K |
| Investing cash flow | 11.68K | -2.57M | -726.63K | -528.42K | 1.19M |
| Financing cash flow | 942.1K | 3.21M | 4.12M | 891.48K | 149.38K |
| Change in cash | -48.18K | -431.93K | 677.72K | -119.55K | 1.27M |
| Net income | -3.47M | -7.25M | -3.19M | -5.23M | -11.39M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SCHEDULE 13G/A — OSR Health, Inc. | View Filing | |
| edgar index | 10-Q — OSR Health, Inc. | View Filing | |
| edgar index | 8-K — OSR Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — OSR Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — OSR Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — OSR Health, Inc. | View Filing | |
| edgar index | PRE 14A — OSR Health, Inc. | View Filing | |
| edgar index | 8-K — OSR Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEFA14A — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — OSR Holdings, Inc. | View Filing | |
| edgar index | 10-Q — OSR Holdings, Inc. | View Filing | |
| edgar index | PRE 14A — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K/A — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | SCHEDULE 13G — OSR Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 3 — OSR Holdings, Inc. | View Filing | |
| form 3 | Form 3 — Kim Yeiseok | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K/A — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-K — OSR Holdings, Inc. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 10-Q — OSR Holdings, Inc. | View Filing | |
| edgar index | 3 — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | DEF 14A — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | PRE 14A — OSR Holdings, Inc. | View Filing | |
| edgar index | 10-Q — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 424B3 — OSR Holdings, Inc. | View Filing | |
| edgar index | 424B3 — OSR Holdings, Inc. | View Filing | |
| edgar index | EFFECT — OSR Holdings, Inc. | View Filing | |
| edgar index | CORRESP — OSR Holdings, Inc. | View Filing | |
| edgar index | S-1/A — OSR Holdings, Inc. | View Filing | |
| edgar index | UPLOAD — OSR Holdings, Inc. | View Filing | |
| edgar index | S-1 — OSR Holdings, Inc. | View Filing | |
| edgar index | 10-Q — OSR Holdings, Inc. | View Filing | |
| edgar index | NT 10-Q — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 10-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K/A — OSR Holdings, Inc. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | NT 10-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing | |
| edgar index | 8-K — OSR Holdings, Inc. | View Filing |